Brief: Resonance Health Says Is Contracted To Provide Liver-Iron-Concentration Quantification Services
27/01/2022 04:35
Jan 27 (Reuters) - Resonance Health Ltd RHT.AX :
* CONTRACTED TO PROVIDE LIVER-IRON-CONCENTRATION
QUANTIFICATION
SERVICES FOR HANGZHOU ZEDE PHARMA-TECH CO
* FERRISCAN TO BE USED BY HANGZHOU ZEDE PHARMA-TECH CO. IN
ITS
PHASE IIB CLINICAL STUDY
Source text for Eikon: ID:nASX4SSRh0
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million